A G Bukrinskaya
Overview
Explore the profile of A G Bukrinskaya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
760
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bukrinskaya A, Vorkunova G, Burshtein M, Stevenson M
Dokl Biol Sci
. 2006 Aug;
408:249-52.
PMID: 16909991
No abstract available.
2.
Bukrinskaya A, Vorkunova G, Burshtein M, Gorodnicheva T, Stevenson M
Dokl Biol Sci
. 2005 Dec;
403:320-2.
PMID: 16358585
No abstract available.
3.
Bukrinskaya A
Arch Virol
. 2004 May;
149(6):1067-82.
PMID: 15168195
HIV-1 particles have been studied by structural and chemical approaches, however, the processes of assembly, budding and maturation are just beginning to be characterized, and molecular details of these processes...
4.
Dupont S, Sharova N, DeHoratius C, Virbasius C, Zhu X, Bukrinskaya A, et al.
Nature
. 1999 Dec;
402(6762):681-5.
PMID: 10604476
An important aspect of the pathophysiology of human immunodeficiency virus type-1 (HIV-1) infection is the ability of the virus to replicate in non-dividing cells. HIV-1 matrix (MA), the amino-terminal domain...
5.
Burstein M, Serbin A, Khakhulina T, Alymova I, Stotskaya L, Bogdan O, et al.
Antiviral Res
. 1999 May;
41(3):135-44.
PMID: 10320046
Newly developed antiviral compounds consisting of an adamantane derivative chemically linked to a water-soluble polyanionic matrix were shown to inhibit HIV-1 infection in lymphoblastoid cells, HeLa CD4+ beta-galactosidase (MAGI) cells...
6.
Bukrinskaya A, Ghorpade A, Heinzinger N, Smithgall T, Lewis R, Stevenson M
Proc Natl Acad Sci U S A
. 1996 Jan;
93(1):367-71.
PMID: 8552640
In the replication of human immunodeficiency virus type 1 (HIV-1), gag MA (matrix), a major structural protein of the virus, carries out opposing targeting functions. During virus assembly, gag MA...
7.
Koken S, Greijer A, Verhoef K, van Wamel J, Bukrinskaya A, Berkhout B
J Biol Chem
. 1994 Mar;
269(11):8366-75.
PMID: 8132560
Human immunodeficiency viruses HIV-1 and HIV-2 encode a Tat protein that specifically activates transcription from the viral long terminal repeat. To characterize the properties of the Tat proteins, we have...
8.
Bukrinskaya A, Vorkunova G, Tentsov YYu
AIDS Res Hum Retroviruses
. 1992 Oct;
8(10):1795-801.
PMID: 1457192
We have shown previously that HIV-1 matrix protein p17 is transported to the nucleus of Jurkat-tat and H9 cells soon after infection. As shown in this combination, gag polyprotein p55...
9.
Bukrinsky M, Sharova N, Dempsey M, Stanwick T, Bukrinskaya A, Haggerty S, et al.
Proc Natl Acad Sci U S A
. 1992 Jul;
89(14):6580-4.
PMID: 1631159
After cell infection by the human immunodeficiency virus type 1 (HIV-1), nascent viral DNA in the form of a high molecular weight nucleoprotein preintegration complex must be transported to the...
10.
Vzorov A, Bukrinsky M, Grigoriev V, Tentsov YYu , Bukrinskaya A
AIDS Res Hum Retroviruses
. 1991 Jan;
7(1):29-36.
PMID: 1901721
CV-1 cells were infected with two recombinant vaccinia viruses carrying the gag gene with deletion of 231 bp from 3' terminus (strain vC5) and env gene (strain vE234L) of human...